Improving treatment for suicidal individuals with PTSD
Enhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals With PTSD
This study is testing if combining prolonged exposure therapy with a crisis response plan can help people with PTSD reduce their suicidal thoughts and behaviors better than standard treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Trial ID | NCT06285708 on ClinicalTrials.gov |
What this trial studies
This study aims to reduce suicidal thoughts and behaviors in individuals with posttraumatic stress disorder (PTSD) by testing the effectiveness of prolonged exposure therapy combined with a crisis response plan. The research will compare this enhanced treatment approach to standard prolonged exposure therapy with a self-guided treatment plan. By integrating trauma-focused therapies with suicide prevention strategies, the study seeks to address a critical gap in existing PTSD treatments. Participants will undergo assessments to evaluate the impact of the combined interventions on their suicidal ideation and attempts.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with PTSD or subthreshold PTSD who can understand and complete the informed consent process.
Not a fit: Patients with substance use disorders requiring medical management or those at imminent risk of suicide may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly lower the risk of suicide among individuals suffering from PTSD.
How similar studies have performed: While prolonged exposure therapy has shown promise in reducing suicidal ideation, this specific combination with a crisis response plan is a novel approach that has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current diagnosis of PTSD or subthreshold PTSD; ability to speak and understand the English language; and ability to complete the informed consent process. Exclusion Criteria: * Substance use disorder requiring medical management; imminent suicide risk warranting inpatient hospitalization or suicide-focused treatment; and impaired mental status that precludes the ability to provide informed consent (e.g., intoxication, psychosis, mania).
Where this trial is running
Columbus, Ohio
- The Ohio State University — Columbus, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Jaryd Hiser, Ph.D. — Assistant Professor
- Study coordinator: Jaryd Hiser, Ph.D.
- Email: jaryd.hiser@osumc.edu
- Phone: 614-814-0163
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.